Research ArticleChemotherapy, Antibiotics, and Gene Therapy
Up-Regulation of Human Prostaglandin Reductase 1 Improves the Efficacy of Hydroxymethylacylfulvene, an Antitumor Chemotherapeutic Agent
Xiang Yu, Melanie M. Erzinger, Kathryn E. Pietsch, Frances N. Cervoni-Curet, John Whang, John Niederhuber and Shana J. Sturla
Journal of Pharmacology and Experimental Therapeutics November 2012, 343 (2) 426-433; DOI: https://doi.org/10.1124/jpet.112.195768
Xiang Yu
Cancer Cell and Biology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland (X.Y., F.N.C.-C., J.W., J.N.); and Eidgenössische Technische Hochschule Zürich, Institute of Food, Nutrition and Health, Zürich, Switzerland (M.M.E., K.E.P., S.J.S.)
Melanie M. Erzinger
Cancer Cell and Biology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland (X.Y., F.N.C.-C., J.W., J.N.); and Eidgenössische Technische Hochschule Zürich, Institute of Food, Nutrition and Health, Zürich, Switzerland (M.M.E., K.E.P., S.J.S.)
Kathryn E. Pietsch
Cancer Cell and Biology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland (X.Y., F.N.C.-C., J.W., J.N.); and Eidgenössische Technische Hochschule Zürich, Institute of Food, Nutrition and Health, Zürich, Switzerland (M.M.E., K.E.P., S.J.S.)
Frances N. Cervoni-Curet
Cancer Cell and Biology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland (X.Y., F.N.C.-C., J.W., J.N.); and Eidgenössische Technische Hochschule Zürich, Institute of Food, Nutrition and Health, Zürich, Switzerland (M.M.E., K.E.P., S.J.S.)
John Whang
Cancer Cell and Biology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland (X.Y., F.N.C.-C., J.W., J.N.); and Eidgenössische Technische Hochschule Zürich, Institute of Food, Nutrition and Health, Zürich, Switzerland (M.M.E., K.E.P., S.J.S.)
John Niederhuber
Cancer Cell and Biology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland (X.Y., F.N.C.-C., J.W., J.N.); and Eidgenössische Technische Hochschule Zürich, Institute of Food, Nutrition and Health, Zürich, Switzerland (M.M.E., K.E.P., S.J.S.)
Shana J. Sturla
Cancer Cell and Biology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland (X.Y., F.N.C.-C., J.W., J.N.); and Eidgenössische Technische Hochschule Zürich, Institute of Food, Nutrition and Health, Zürich, Switzerland (M.M.E., K.E.P., S.J.S.)
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleChemotherapy, Antibiotics, and Gene Therapy
Human PTGR1 Activates Acylfulvenes and Improves Efficacy
Xiang Yu, Melanie M. Erzinger, Kathryn E. Pietsch, Frances N. Cervoni-Curet, John Whang, John Niederhuber and Shana J. Sturla
Journal of Pharmacology and Experimental Therapeutics November 1, 2012, 343 (2) 426-433; DOI: https://doi.org/10.1124/jpet.112.195768
Research ArticleChemotherapy, Antibiotics, and Gene Therapy
Human PTGR1 Activates Acylfulvenes and Improves Efficacy
Xiang Yu, Melanie M. Erzinger, Kathryn E. Pietsch, Frances N. Cervoni-Curet, John Whang, John Niederhuber and Shana J. Sturla
Journal of Pharmacology and Experimental Therapeutics November 1, 2012, 343 (2) 426-433; DOI: https://doi.org/10.1124/jpet.112.195768
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement